Atrys Health SA

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: ES0105148003

EUR

2.72

0.02 (0.74%)

Dec 12

MCE

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Atrys Health SA

EuroEspes SA

Why is Atrys Health SA ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0.44%

Poor long term growth as Operating profit has grown by an annual rate 39.07% of over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -11.11%, its profits have risen by 25%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -11.11% returns in the last 1 year, the stock has also underperformed Spain IBEX 35 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Atrys Health SA for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Atrys Health SA

-11.4%

-0.78

36.48%

Spain IBEX 35

43.26%

2.49

17.33%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

85.05%

EBIT Growth (5y)

39.07%

EBIT to Interest (avg)

-0.57

Debt to EBITDA (avg)

7.47

Net Debt to Equity (avg)

0.83

Sales to Capital Employed (avg)

0.33

Tax Ratio

4.85%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.44%

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.05

EV to EBIT

78.62

EV to EBITDA

13.29

EV to Capital Employed

1.03

EV to Sales

2.11

PEG Ratio

Dividend Yield

ROCE (Latest)

1.31%

ROE (Latest)

-10.67%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Atrys Health SA

Net Sales - Half-Yearly

At EUR 83 MM has Grown at 19.98 %

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (EUR MM)

Cash and Cash Equivalents - Half Yearly

Highest at EUR 41.83 MM

in the last six half yearly periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents (EUR MM)

Here's what is not working for Atrys Health SA

Interest - Annual

At EUR 33.05 MM has Grown at 127.38 %

over previous Year

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)